Krystexxa Injection, Solution
Product Images NDC 75987-080

1 FDA label image from Horizon Therapeutics Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Krystexxa (NDC 75987-080). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Horizon Therapeutics Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (8 mg/mL Vial Carton)

Principal Display Panel (8 mg/mL Vial Carton)
Packaging label for Krystexxa 8 mg/mL injection solution for intravenous infusion by Horizon Therapeutics USA, Inc. The label includes product name, strength, dosage form, storage instructions, manufacturer and distributor information, NDC number 75987-080-10, and usage notes such as single-dose vial and requirement to dilute prior to administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.